Order results by:
Issue | Title | |
Vol 11, No 4 (2017) | A PEN INJECTOR FOR SELF-ADMINISTRATION OF FOLLITROPIN ALPHA SOLUTION WITH A MINIMAL DOSE INCREMENT OF 5 IU | Abstract similar documents |
A. B. Podkorytov, O. V. Zhilyaev, M. A. Polzikov | ||
"... ) are carried out using pen injectors with minimal dose increments of 8.33 IU or 12.5 IU (IU – international ..." | ||
Vol 11, No 3 (2017) | THE NOVEL BIOSIMILAR OF FOLLITROPIN ALPHA TO BE MANUFACTURED IN RUSSIA STARTING FROM 2017 | Abstract similar documents |
I. I. Vorobiev, A. S. Semikhin, E. O. Golovina | ||
"... , the recombinant FSH biosimilar will be produced in disposable injectors (pen-injector) that provide easy-to-use ..." | ||
Vol 16, No 2 (2022) | Anticoagulants: dose control methods and inhibitors | Abstract PDF (Eng) similar documents |
V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, V. I. Tsibizova, N. R. Gashimova, I. A. Nakaidze, I. Elalamy, J.-C. Gris, A. D. Makatsariya | ||
Vol 15, No 1 (2021) | An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data | Abstract similar documents |
D. P. Kamilova, M. M. Ovchinnikova, E. Sh. Ablyaeva, M. M. Leviashvili, N. S. Stuleva, E. V. Broitman, M. A. Ganikhina, E. N. Mayasina, L. F. Iskhakova, K. Yu. Boyarskiy, E. N. Ovsyannikova, Z. B. Barakhoeva, S. V. Nikitin, I. A. Bendusov, Yu. A. Fetisova, M. A. Yudina, E. S. Tararashkina, D. T. Khetagurova, D. V. Blinov, M. A. Polzikov | ||
"... study of follitropin alpha biosimilar (Primapur®) as a pre-filled pen injector with a dose adjustment ..." | ||
Vol 17, No 5 (2023) | Effect of same dose varying concentration poractant alfa on outcomes in preterm infants under 32 weeks of age | Abstract PDF (Eng) similar documents |
A. V. Mostovoi, A. L. Karpova, S. S. Mezhinsky, N. N. Volodin | ||
"... . Conclusion. PA administered at concentration of 40 mg/mL without changing the recommended dose did ..." | ||
Vol 8, No 3 (2014) | VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY | Abstract similar documents |
I. E. Zazerskaya, N. A. Osipova, T. V. Vavilova, L. V. Barabanova, K. S. Konradi | ||
"... литературы относительно выбора дозы и длительности применения низкомолекулярных гепаринов для профилактики ..." | ||
Vol 9, No 3 (2015) | PREGNANCY AND DELIVERY IN WOMEN WITH A HISTORY OF PREECLAMPSIA HYPERHOMOCYSTEINEMIA TREATED WITH BEMIPARIN IN COMBINATION WITH LOW-DOSE ASPIRIN | Abstract similar documents |
L. O. Buzyan, G. G. Buzyan, V. F. Dolgushina | ||
Vol 17, No 4 (2023) | What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas? | Abstract similar documents |
V. O. Bitsadze, M. S. Zainulina, J. Kh. Khizroeva, M. G. Nikolaeva, A. D. Makatsariya | ||
Vol 5, No 4 (2011) | METRONIDAZOLE EFFICIENCY IN PREPARATIONS FOR CAESAREAN SECTION IN WOMEN WITH BACTERIAL VAGINOSIS | Abstract similar documents |
A. A. Badaeva, V. G. Volkov | ||
"... during postnatal period among women with bacterial vaginosis treated by metronidazole in a dose of 500 mg ..." | ||
Vol 16, No 1 (2022) | Thrombosis risk and in vitro fertilization | Abstract similar documents |
E. Grandone | ||
"... preventive LMWH dose in such patient cohort may not always be sufficient. On the other hand, escalating dose ..." | ||
Vol 8, No 3 (2014) | ELIMINATION OF CHRONIC PELVIC PAIN CAUSED BY ADENOMYOSIS THE PROGESTOGENS NEW GENERATION | Abstract similar documents |
M. R. Orazov, A. V. Chayka, E. N. Nosenko | ||
"... of progestogen-new generation dienogest in a dose of 2 mg for 6 months. The study included 44 (n=44) women ..." | ||
Vol 18, No 4 (2024) | Septic shock in obstetrics: the role of efferent techniques for endotoxin removal in Gram-negative sepsis | Abstract similar documents |
A. Zh. Bayalieva, V. R. Davydova | ||
"... BK-2.1U. Lipopolysaccharide (LPS) doses corresponding to severity of the septic process were ..." | ||
Vol 12, No 1 (2018) | MANAGEMENT OF PREGNANCY AND DELIVERY IN A WOMAN WITH HOMOZYGOUS MUTATION OF PROTHROMBIN (Thr165Met) AND RECURRENT PULMONARY EMBOLISM ON THE BACKGROUND OF HORMONAL CONTRACEPTION | Abstract similar documents |
N. M. Khamani | ||
"... of pregnancy, delivery and the postpartum period included carefully selected doses of low-molecular weight ..." | ||
Vol 5, No 1 (2011) | MODERN APPROACHES TO THERAPY OF UROGENITAL DISORDERS IN POST-MENOPAUSAL FEMALES | Abstract similar documents |
T. S. Perepanova, P. L. Khazan | ||
"... the deficiency of female sex hormones. Topical administration of therapeutic doses of estriol as a cream ..." | ||
Vol 16, No 2 (2022) | Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia | Abstract similar documents |
E. A. Orudzhova, V. O. Bitsadze, M. V. Tretyakova, D. A. Doronicheva, F. Yakubova | ||
"... Aim: to evaluate the effectiveness of using low molecular weight heparin (LMWH) and low-dose ..." | ||
Vol 12, No 2 (2018) | Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype) | Abstract similar documents |
M. G. Nikolaeva, A. P. Momot, M. S. Zainulina, K. A. Momot, N. N. Yasafova | ||
"... doses. The comparison group (71 pregnant women of 30.3 ± 3.9 years old) received no LMWH. Results ..." | ||
Vol 17, No 4 (2023) | The efficacy of GnRH agonist trigger followed by hCG add-back in normal responders for fresh embryo transfer: a case-control analysis from Vietnam | Abstract PDF (Eng) similar documents |
M.T. Le, N.S.V. Le, N.Q.T. Tran, Q.H.V. Nguyen, T.N. Cao | ||
"... and low-dose human chorionic gonadotropin (hCG) on in vitro fertilization (IVF) outcomes in women ..." | ||
Vol 18, No 6 (2024) | Opportunities of combination therapy in reproductive age patients with bacterial vaginosis combined with vulvovaginal candidiasis | Abstract similar documents |
I. V. Savelieva, E. A. Bukharova, E. G. Galyanskaya, N. V. Nosova, P. V. Davydov | ||
"... dose – thioconazole 100 mg, tinidazole 150 mg in the form of a suppository) and Gainomax plus (standard ..." | ||
Vol 17, No 2 (2023) | Ovarian stimulation methods at a single-assisted reproductive technology institution: a retrospective study of successful outcomes | Abstract PDF (Eng) similar documents |
Y. Horibe, A. Nakabayashi, S. Murata, T. Hashimoto, T. Tabata | ||
"... was observed. The FSH was used in CH group and non-CH group at dose of 1108 ± 468 IU and 1756 ± 394 IU ..." | ||
Vol 14, No 4 (2020) | Individualized correction of sex steroid deficiency in early postmenopausal women with uterine leiomyoma | Abstract similar documents |
M. V. Koval, T. A. Oboskalova | ||
"... ) – low-dose drug estradiol 1 mg/drospirenone 2 mg, Group 2 (n = 60) – ultra-low-dose drug estradiol 0 ..." | ||
Vol 17, No 2 (2023) | Complications and outcomes of pregnancy in patients with antiphospholipid antibodies during various treatment methods | Abstract similar documents |
Yu. S. Bagdasarova, M. S. Zainulina, M. G. Nikolaeva | ||
"... of developing obstetric and thrombotic complications, all patients were prescribed prophylactic doses of low ..." | ||
Vol 11, No 3 (2017) | USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES | Abstract similar documents |
M. I. Krivonos, M. S. Zainulina, E. A. Kornyushina, S. V. Chepanov, S. A. Selkov | ||
"... were enrolled: 77 women were given IVIG during the IVF procedure at a course dose of 15 g (group 1 ..." | ||
Vol 12, No 3 (2018) | Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®) | Abstract similar documents |
Z. B. Barakhoeva, L. A. Vovk, I. V. Zorina, N. Yu. Belousova, T. A. Teterina, S. A. Yakovenko, V. P. Apryshko, Yu. A. Fetisova, N. A. Marilova, E. G. Morozova, M. M. Ovchinnikova, M. A. Tishenko, Yu. V. Sherbatyuk, A. V. Kolotovkina, A. A. Miskun, G. V. Kasyanova, L. G. Sichinava, R. I. Shalinа, M. A. Polzikov | ||
"... of fertilized oocytes, the number of days of stimulation, the total dose of the injected drug, the occurrence ..." | ||
Vol 14, No 6 (2020) | Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis | Abstract similar documents |
M. I. Yarmolinskaya, M. A. Shalina, C. I. Seyidova | ||
"... loss of BMD and reduces risk of cardiovascular diseases. Using low and ultra-low dose estrogen ..." | ||
Vol 15, No 6 (2021) | Risks of venous thromboembolic complications in related to combined oral contraceptives | Abstract similar documents |
K. A. Gabelova, N. A. Shabanova, V. F. Bezhenar, E. E. Zvartau, Yu. A. Akishina | ||
"... application of hormonal contraception to reduce dose of its estrogen component and improving quality ..." | ||
Vol 10, No 3 (2016) | ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY | Abstract similar documents |
A. V. Khromylev, A. D. Makatsariya | ||
"... delivery in a dose of 40 mg daily, with further dose adjustment. Results. According to the results ..." | ||
Vol 15, No 4 (2021) | Management of antithrombin III deficiency in pregnancy: a representative case and a literature review | Abstract PDF (Eng) similar documents |
S. V. Akinshina, P. K. Genina, V. O. Bitsadze, J. Kh. Khizroeva, V. I. Tsibizova, A. D. Makatsariya | ||
"... thrombotic and obstetric complications even despite using therapeutic doses of anticoagulants. Indications ..." | ||
Vol 9, No 2 (2015) | Insufficiency of luteal phase defect an assessment of criteria in patients with endocrine forms of infertility | Abstract similar documents |
A. G. Davudova | ||
"... , to choose an individual, pathogenetically substantiated treatment strategy, to select the doses and to avoid ..." | ||
Vol 15, No 1 (2021) | Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies | Abstract similar documents |
D. R. Eremeeva, M. S. Zainulina, Yu. S. Dolgova, R. A. Shakhaliev, O. A. Silvanovich, L. A. Pavlova | ||
"... pregnancy outcome. 36 (62.1 %) women had pregnancy loss in anamnesis. All patients received low-dose ASA ..." | ||
Vol 15, No 5 (2021) | Prophylaxis and management of venous thromboembolism during pregnancy and postpartum period | Abstract similar documents |
V. Ya. Khryshchanovich, N. Ya. Skobeleva | ||
"... -adjusted therapeutic-dose low molecular weight heparins (LMWH) represent the anticoagulant treatment ..." | ||
Vol 9, No 3 (2015) | THE TREATMENT OF DIFFUSE BENIGN BREAST DISEASE AND MASTODYNIA | Abstract similar documents |
N. I. Rozhkova, I. I. Burdina, S. B. Zapirova, M. L. Mazo, S. P. Prokopenko, O. E. Yakobs | ||
"... of severity. All the patients had been appointed Mastopol in standard doses. After one course of treatment (8 ..." | ||
Vol 14, No 2 (2020) | Postoperative management of patients with endometriosis | Abstract similar documents |
Ju. E. Dobrokhotova, D. M. Kalimatova, I. Yu. Ilyina | ||
"... . Thus, a combination treatment of endometriosis containing dienogest at a dose of 2 mg/day applied ..." | ||
Vol 18, No 1 (2024) | The role of epigenetics in male and female infertility | Abstract similar documents |
D. A. Egorova, V. V. Derezina, M. V. Chebanyan, M. B. Sultonova, T. V. Ishmuratov, M. M. Gasanov, A. Z. Chipchikova, S. A. Paksileva, S. S. Mitkina, R. R. Khamidullina, A. Sh. Kutueva, A. A. Anikeeva | ||
"... dose has not yet been determined, it was noted that such parameters may positively influence fertility ..." | ||
Vol 18, No 4 (2024) | Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies | Abstract similar documents |
D. R. Eremeeva, M. S. Zainulina | ||
"... . All pregnant women received therapy with low-dose aspirin (LDA) and low molecular weight heparin ..." | ||
Online First | Normalization of the balance of estrogens and androgens in men with hyperestrogenism using a drug of the class of aromatase inhibitors – letrozole | Abstract similar documents |
Z. Sh. Pavlova, A. S. Ametov, I. I. Golodnikov, A. A. Kamalov | ||
"... prescribed letrozole (at a dose of 2.5 mg 2 times a week); patients in Group 2 (n = 23) received only ..." | ||
Vol 16, No 1 (2022) | Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class | Abstract similar documents |
Z. Sh. Pavlova, A. S. Ametov, I. I. Golodnikov, A. A. Kamalov | ||
"... standard metformin therapy (1000 mg 2 times a day), along with letrozole (at a dose of 2.5 mg 2 times ..." | ||
Vol 15, No 2 (2021) | Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation | Abstract similar documents |
O. L. Mysik, M. S. Zainulina | ||
"... and LMWH in prophylactic doses for 4 weeks; pregnant comparison groups (n = 125) received no such drugs ..." | ||
Vol 18, No 5 (2024) | Advantages, disadvantages and optimization of organ-sparing methods for uterine fibroids treatment | Abstract similar documents |
A. L. Tikhomirov, V. V. Kazenashev, O. V. Maksimova, M. V. Maminova, N. L. Davydenko, N. V. Rurua, T. A. Sonina | ||
"... at a daily dose of 5 mg for 84 days (one course) with an interval until the onset of second menstruation ..." | ||
Vol 4, No 3 (2010) | LOCAL TREATMENT OF PERI- AND POSTMENOPAUSAL UROGENITAL DISORDERS | Abstract similar documents |
T. V. Ovsyannikova, I. O. Makarov, E. I. Borovkova, I. A. Kulikov | ||
"... the treatment course is shown the transition to supportive / preventive dose to prevent the resumption ..." | ||
No 4 (2008) | Урогенитальные расстройства климактерического периода. Часть 2: этиология, патогенез, диагностика | Abstract similar documents |
, | ||
"... дозу с целью предотвращения возобновления симптомов урогенитальной атрофии. ..." | ||
Vol 13, No 1 (2019) | Information on the combined hormonal contraceptives (CHC) containing the dienogest + ethinyl estradiol combination (Jeanine®) | Abstract similar documents |
A. D. Makatsariya, V. O. Bitsadze, D. V. Blinov, D. I. Korabelnikov | ||
"... of the combined hormonal contraceptive (CHC) Jeanine®, containing the fixed dose combination of dienogest ..." | ||
Vol 6, No 1 (2012) | NON-DEVELOPING PREGNANCY. THE ROLE OF HORMONAL CONTRACEPTION IN REHABILITATION TREATMENT | Abstract similar documents |
G. B. Dikke | ||
"... rationale to use modern low-dose COCs containing last generation progestagen desogestrel for restore ..." | ||
Vol 4, No 2 (2010) | POLYCYSTIC OVARIAN SYNDROME | Abstract similar documents |
T. D. Guriev | ||
"... or low dose, single phase, third generation oral contraceptives (COC) combined with progestagens ..." | ||
Vol 6, No 1 (2012) | VAGINAL CANDIDOSIS. ALTERNATIVES OF PHARMACOTHERAPY | Abstract similar documents |
L. O. Makarov, N. A. Sheshukova | ||
"... assigned to fenticonazol 600 mg for vaginal administration, and to its repeated dose (600 mg) in three days ..." | ||
Vol 17, No 5 (2023) | Chemotranscriptomic analysis of 7-hydroxymatairesinol-related effects on MCF7 human breast tumor cells | Abstract similar documents |
I. Yu. Torshin, A. N. Rubashkina, O. A. Gromova | ||
"... samples of data from transcriptomic studies allowing to model dose-dependent compound-related effects ..." | ||
Vol 14, No 4 (2020) | One of the trends of oxidative protection in in vitro fertilization programs | Abstract similar documents |
O. S. Vachlova, T. A. Oboskalova | ||
"... after adding it to culture medium. Such effects demonstrated dose-depended pattern. Taking into account ..." | ||
Vol 7, No 3 (2013) | SYSTEMATIC ANALYSIS OF FUNDAMENTAL AND CLINICAL RESEARCH, AS JUSTIFICATION FOR THE USE OF ESTROGEN-CONTAINING DRUGS WITH THE PREPARATIONS OF MAGNESIUM AND PYRIDOXINE | Abstract similar documents |
O. A. Gromova, O. A. Limanova, I. Yu. Torshin | ||
"... -epidemiological studies showed that intake of estrogen preparations, even of the so-called low-dose ones ..." | ||
Vol 13, No 3 (2019) | Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018 | Abstract similar documents |
A. D. Makatsariya, D. V. Blinov, V. O. Bitsadze, J. Kh. Khizroeva | ||
"... . The confirmed efficacy and safety of estriol allow for its permanent use, beginning with the starting dose ..." | ||
Vol 9, No 4 (2015) | THE MECHANISMS OF SECONDARY OVARIAN FAILURE AT OPERATIONS ON THE PELVIC ORGANS (EXPERIMENTAL STUDY) | Abstract similar documents |
I. A. Petrov, O. A. Tihonovskaja, I. I. Kuprijanova, A. O. Okorokov, S. V. Logvinov, M. S. Petrova, L. A. Agarkova | ||
"... концентрации АМГ и Т и не влияет на ФСГ. Применение DHEA в дозе 1 мг/сут. в течение 28 дней не изменяет ..." | ||
1 - 50 of 51 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)